CAELYX
Google image searchProduct monograph
Active ingredient
doxorubicin hydrochloride, 2 MG/ML
DIN: 02238389
Dosage form(s): SUSPENSION
Route(s) of administration: INTRAVENOUS
Description: SINGLE-USE VIALS
Schedule: Prescription
Company: BAXTER CORPORATION
Date: 04-MAR-2022
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01D — CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES (ATC, ATC/DDD)
- L01DB — Anthracyclines and related substances (ATC, ATC/DDD)
- L01DB01 — DOXORUBICIN (ATC/DDD)
Reference brand drug: Adriamycin
